Peptide ProvidersDirect

Topic pillar

Safety and regulation

How to distinguish approved, compounded, off-label, investigational, and unapproved products.

Primary research topic: are peptides FDA approved

Guides in this topic

Use these guides together: begin with the overview, follow the verification steps, and confirm time-sensitive regulatory information through the linked primary sources.

Regulatory guide

CJC-1295: what consumers should verify

CJC-1295 is often marketed in growth-hormone-related programs and in combinations. This guide separates what is known, what is marketed, and what consumers can verify before choosing a provider.

4 sections · 4 FAQs · 2 sources

Read guide →
Regulatory guide

Semax: regulatory status and marketing claims

Semax is promoted online for cognitive and wellness purposes, including in nasal products. This guide separates what is known, what is marketed, and what consumers can verify before choosing a provider.

4 sections · 4 FAQs · 2 sources

Read guide →
Regulatory guide

TB-500: what the name means and what to verify

TB-500 marketing frequently overlaps with thymosin-beta-4 language, recovery claims, and research-product sellers. This guide separates what is known, what is marketed, and what consumers can verify before choosing a provider.

4 sections · 4 FAQs · 3 sources

Read guide →
Regulatory guide

GHK-Cu: topical and injectable claims explained

GHK-Cu appears in cosmetic, topical, and injectable marketing, which are not interchangeable uses. This guide separates what is known, what is marketed, and what consumers can verify before choosing a provider.

4 sections · 4 FAQs · 2 sources

Read guide →
Regulatory guide

Thymosin alpha-1: evidence and approval questions

Thymosin alpha-1 may be discussed using immune-health language that can imply treatment claims. This guide separates what is known, what is marketed, and what consumers can verify before choosing a provider.

4 sections · 4 FAQs · 3 sources

Read guide →